C50S (p.Cys50Ser) variant of UMOD (Uromodulin)

C50S (p.Cys50Ser) in UMOD (Uromodulin) is a missense change. Clinical records from ClinVar and UniProt describe it as likely pathogenic in the context of Familial juvenile hyperuricemic nephropathy type 1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.96 / 1. The record also includes published literature and structural context.

C50S (p.Cys50Ser) variant details